Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study

被引：0
|
作者：
Mingot-Castellano, Maria Eva [1 ]
Alvarez-Roman, Maria Teresa [2 ]
Lozano, Maria Luisa [3 ]
Miesbach, Wolfgang [4 ]
Qureshi, Hafiz [5 ]
Mcdonald, Vickie [6 ]
Putnik, Milica [7 ]
Zhang, Jessica [8 ]
Skuban, Nina [8 ]
Garcia, Viridiana Cano [8 ]
Lethagen, Stefan [7 ]
机构：
[1] Hosp Univ Virgen Rocio, Seville, Spain
[2] Hosp Univ La Paz, Madrid, Spain
[3] Hosp Univ Morales Meseguer, Murcia, Spain
[4] Univ Hosp Frankfurt, Frankfurt, Germany
[5] Univ Hosp Leicester NHS Trust, Leicester, England
[6] Guys & St Thomas NHS Fdn Trust, London, England
[7] Sobi, Stockholm, Sweden
[8] Sobi, Waltham, MA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203491
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [31] A LONGITUDINAL PROSPECTIVE STUDY EVALUATING THE EFFECTS OF ELTROMBOPAG TREATMENT ON BONE MARROW IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA: INTERIM ANALYSIS AT 2 YEARS
    Brynes, R.
    Orazi, A.
    Wong, R.
    Bakshi, K.
    Bailey, C.
    Chan, G.
    HAEMATOLOGICA, 2013, 98 : 195 - 195
  • [32] EFFICACY OF RITUXIMAB IN COMBINATION WITH DEXAMETHASONE VS DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA - AN INTERIM ANALYSIS OF A PROSPECTIVE RANDOMISED STUDY
    Gudbrandsdottir, S.
    Frederiksen, H.
    Helleberg, I.
    Jensen, B.
    Kjeldsen, L.
    Klausen, T.
    Larsen, H.
    Mounts-Andersen, H. T.
    Nielsen, C. H.
    Nielsen, O. J.
    Plesner, T.
    Pulczynski, S.
    Roennow-Jessen, D.
    Hasselbalch, H. C.
    Birgens, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 253 - 253
  • [33] A Longitudinal Prospective Study Evaluating the Effects of Eltrombopag Treatment On Bone Marrow in Patients with Chronic Immune Thrombocytopenia: Interim Analysis At 1 Year
    Brynes, Russell K.
    Orazi, Attilio
    Wong, Raymond S. M.
    Bakshi, Kalpana
    Bailey, Christine K.
    Brainsky, Andres
    BLOOD, 2012, 120 (21)
  • [34] Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry B.
    Liebman, Howard A.
    Lee, Susie
    Bernheisel, Chelsea
    Kolodny, Scott
    Wojdyla, Matthew
    Vredenburg, Michael
    Jamieson, Brian
    Cuker, Adam
    BLOOD, 2021, 138
  • [35] Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry
    Liebman, Howard
    Lee, Susie
    Wojdyla, Matthew
    Vredenburg, Michael
    Cuker, Adam
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (03) : 359 - 366
  • [36] Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry
    Tomasello, Riccardo
    Garabet, Lamya
    Pettersen, Heidi
    Tjonnfjord, Eirik
    Tsykunova, Galina
    Pedersen, Torkild
    Tran, Hoa
    Napolitano, Mariasanta
    Ghanima, Waleed
    BLOOD, 2023, 142
  • [37] Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)
    Izquierdo, Maria Cristina Pascual
    Gonzalez, Blanca Sanchez
    Hinryk, Mariana Canaro
    Gabaldon, Gloria Garcia-Donas
    Gomez, Maria Menor
    Fernandez, Juan Jose Gil
    Saornil, Silvia Monsalvo
    Roman, Maria Teresa Alvarez
    Jarque, Isidro
    Ferrandis, Maria Jose Llacer
    Zafra, Denis
    Miranda, Isabel Caparros
    Pasalodos, Ariana Ortuzar
    Revilla, Nuria
    Bermejo, Jose Maria Bastida
    Outeiro, Montserrat Alvarellos
    Barcenas, Reyes Jimenez
    Bernat, Silvia Bernat
    Gullon, Esther Chica
    Carballeira, Daniel Martinez
    Lakhwani, Sunil
    Ansoar, Elsa Lopez
    Beltran, Esperanza Moreno
    Vizcaya, Alvaro Lorenzo
    Maldonado, Marta Canet
    Gascon, Isabel Gonzalez y
    Navarro, Gonzalo Caballero
    Cuesta, Amalia
    Pedrote, Begona
    Arrizabalag, Maria Aranzazu Aguirre
    Eguialde, Maialen Lasa
    Carbonell, Marta Moreno
    Lopez, Alicia Ortiz
    Castellano, Eva Mingot
    BLOOD, 2024, 144 : 713 - 715
  • [38] Clinical Predictors of Response to Rilzabrutinib Therapy in Patients with Immune Thrombocytopenia: Exploratory Analysis of a Phase 1/2 Study
    Kuter, David J.
    Ghanima, Waleed
    Khan, Umer
    Li, Mengyao
    Shan, Jenny
    Daak, Ahmed
    Cooper, Nichola
    BLOOD, 2022, 140 : 5559 - 5561
  • [39] Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis
    Lu, Jun
    Jamieson, Brian D.
    Hui, Ai-Min
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [40] Absence of Plasma Gastric Biomarker Elevations with Chronic Dosing of Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, in Patients with Chronic Immune Thrombocytopenia in Phase 3 Trials
    Bussel, James B.
    Allen, Lee F.
    Tian, Wei
    Kuter, David J.
    BLOOD, 2018, 132
12345